Perceived utility of electrodiagnostic testing in critical illness myopathy and polyneuropathy: A survey of intensive care unit providers.
critical illness
electrodiagnostic studies
myopathy
polyneuropathy
weakness
Journal
Muscle & nerve
ISSN: 1097-4598
Titre abrégé: Muscle Nerve
Pays: United States
ID NLM: 7803146
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
14
04
2022
received:
23
06
2021
accepted:
17
04
2022
pubmed:
27
4
2022
medline:
16
6
2022
entrez:
26
4
2022
Statut:
ppublish
Résumé
Critical illness myopathy (CIM) and critical illness polyneuropathy (CIP) are common disorders associated with substantial morbidity. Electrodiagnostic studies (EDx) are effective in diagnosing CIM/CIP and identifying mimicking conditions. We surveyed intensive care unit (ICU) providers to better understand their approach to ICU-acquired weakness (ICU-AW) and the perceived utility of EDx. This was a single health system, Web-based survey of ICU providers. Survey responses were received from 52 providers with a response rate of 22.1%. Most providers were somewhat familiar with CIM/CIP and median perceived prevalence was 30-49%. The majority (92.3%) of providers had no standard evaluation approach for ICU-AW. Electrodiagnostic testing was commonly considered, but many providers obtained it infrequently in presumed CIM/CIP cases. Electrodiagnostic studies were used to rule out other causes of weakness or to confirm the diagnosis of CIM/CIP. Many providers ordered EDx within 1 wk of identifying weakness. Finally, EDx were overshadowed by personal experience as the most helpful management tool for ICU-AW. Overall, ICU providers perceive that CIM/CIP are commonly encountered, but they may not have a standard approach to evaluation. Clinical experience increased familiarity of ICU-AW and is central to management. EDx results are usually thought to be helpful, albeit not often ordered, and more study is needed to determine when implementation is of most assistance. Increasing education and developing institutional standards may lead to increased awareness and improved evaluation of CIM/CIP, but more study is needed to determine if algorithmic approaches would change patient outcomes.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
90-95Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33(11):1876-1891.
Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931-941.
Koch S, Spuler S, Deja M, et al. Critical illness myopathy is frequent: accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiat. 2011;82(3):287-293.
Herridge MS, Tansey CM, Matte A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293-1304.
De Jonghe B, Bastuji-Garin S, Durand MC, et al. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med. 2007;35(9):2007-2015.
Teixeira C, Rosa RG, Maccari JG, Savi A, Rotta FT. Association between electromyographical findings and intensive care unit mortality among mechanically ventilated acute respiratory distress syndrome patients under profound sedation. Rev Bras Ter Intens. 2019;31(4):497-503.
Wieske L, Dettling-Ihnenfeldt DS, Verhamme C, et al. Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study. Crit Care. 2015;19(1):196-198.
Lacomis D, Zochodne DW, Bird SJ. Critical illness myopathy. Muscle Nerve. 2000;23(12):1785-1788.
Hermans G, Mechelen HV, Clerckx B, et al. Acute outcomes and 1-year mortalitiy of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190(4):410-420.
Van Aerde N, Meersseman P, Debaveye Y, et al. Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study. Intensive Care Med. 2020;46(6):1184-1193.
Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve. 2005;32(2):140-163.
Lacomis D. Electrophysiology of neuromuscular disorders in critical illness. Muscle Nerve. 2013;47(3):452-463.
Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev. 2014;1:1-54.
Stevens RD, Marshall SA, Cornblath DR, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med. 2009;37(10 Suppl):S299-S308.
Lacomis D, Petrella JT, Giuliani MJ. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve. 1998;21(5):610-617.
Ojha A, Zivkovic SA, Lacomis D. Electrodiagnostic studies in the intensive care unit: a comparison study 2 decades later. Muscle Nerve. 2018;57(5):772-776.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software partners. J Biomed Inform. 2019;95:103208.
Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637-653.
Latronico N, Nattino G, Fagoni N, et al. Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study. F1000Res. 2014;3(127):1-16.
Moss M, Yang M, Macht M, et al. Screening for critical illness polyneuromyopathy with single nerve conduction studies. Intensive Care Med. 2014;40(5):683-690.
Shepherd SJ, Newman R, Brett SJ, Griffith DM. Pharmacological therapy for the prevention and treatment of weakness after critical illness: a systematic review*. Crit Care Med. 2016;44(6):1198-1205.
Alhurani RE, Oeckler RA, Franco PM, Jenkins SM, Gajic O, Pannu SR. Refractory hypoxemia and use of rescue strategies. A U.S. National Survey of adult intensivists. Ann Am Thorac Soc. 2016;13(7):1105-1114.
Cunningham CT, Quan H, Hemmelgarn B, et al. Exploring physician specialist response rates to web-based surveys. BMC Med Res Methodol. 2015;15(1):32-38.
Opgenorth D, Stelfox HT, Gilfoyle E, et al. Perspectives on strained intensive care unit capacity: a survey of critical care professionals. PLoS One. 2018;13(8):e0201524.
Matteson KA, Anderson BL, Pinto SB, Lopes V, Schulkin J, Clark MA. Surveying ourselves: examining the use of a web-based approach for a physician survey. Eval Health Prof. 2011;34(4):448-463.
Poncette A-S, Mosch L, Spies C, et al. Improvements in patient monitoring in the intensive care unit: survey study. J Med Internet Res. 2020;22(6):e19091.
Robertson J, Walkom EJ, McGettigan P. Response rates and representativeness: a lottery incentive improves physician survey return rates. Pharmacoepidemiol Drug Saf. 2005;14(8):571-577.
Sebo P, Maisonneuve H, Cerutti B, Fournier JP, Senn N, Haller DM. Rates, delays, and completeness of general Practitioners' responses to a postal versus web-based survey: a randomized trial. J Med Internet Res. 2017;19(3):e83.
Turnbull AE, O'Connor CL, Lau B, Halpern SD, Needham DM. Allowing physicians to choose the value of compensation for participation in a web-based survey: randomized controlled trial. J Med Internet Res. 2015;17(7):e189.